[Echocardiographic evaluation of coronary flow reserve in patients with essential hypertension]
- PMID: 11830712
[Echocardiographic evaluation of coronary flow reserve in patients with essential hypertension]
Abstract
Background: In patients with essential arterial hypertension (EAH) the left heart ventricular hypertrophy (LVH) causes structural and functional alterations of the coronary vessels that can alter the coronary blood flow reserve. The aim of this study is to evaluate in hypertensive patients with or without LVH versus normotensive subjects, the blood flow and the coronary vasodilatation capability and the coronary blood flow reserve in basal conditions and during dipiridamole i.v. infusion.
Methods: Eighty patients have been selected by ECG, echo color Doppler, transesophageal echocardiography: 50 were hypertensive patients with and without LVH, from mild to moderate to severe and 30 were normotensive subjects. The enrolled patients underwent a first transesophageal echocardiography, before and during infusion of 0.86 mg/kg of dipiridamole in growing doses, 0.56 in four minutes followed after three minutes by 0.30 mg/kg. The observation lasted 18 months, and no patients left the study.
Results: The coronary resistances in hypertensive patients were significintally reduced during dipiridamole infusion, maintaining their level higher compared to the normal controls. The reduced coronary vasodilatation capability in hypertensive subjects could be due to an increase of the basal vessel tone and/or a reduced compliance of the coronary resistances. The coronary blood flow reserve is significantly reduced in all hypertensive studied, included those without LVH. It is suggested that this is secondary to increase of the coronary blood flow and tone.
Conclusions: In conclusion essential arterial hypertension is the cause of early anatomical and functional coronary alterations leading hypertensive subjects to risk for coronary events before LVH.
Similar articles
-
Coronary flow velocity reserve is diminished in hypertensive left ventricular hypertrophy.Kardiol Pol. 2005 Jan;62(1):1-5. Kardiol Pol. 2005. PMID: 15815773
-
Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy.Blood Press. 2010 Feb;19(1):40-7. doi: 10.3109/08037050903450492. Blood Press. 2010. PMID: 20001392 Clinical Trial.
-
In patients with hypertensive left ventricular hypertrophy and coronary heart disease, coronary flow reserve is similarly impaired.Chin Med Sci J. 1995 Sep;10(3):151-7. Chin Med Sci J. 1995. PMID: 8580484
-
New echocardiographic technologies in the clinical management of hypertensive heart disease.J Cardiovasc Med (Hagerstown). 2007 Dec;8(12):997-1006. doi: 10.2459/JCM.0b013e3281053ad2. J Cardiovasc Med (Hagerstown). 2007. PMID: 18163010 Review.
-
The importance of left ventricular hypertrophy in human hypertension.J Hypertens Suppl. 1998 Sep;16(7):S23-9. J Hypertens Suppl. 1998. PMID: 9855028 Review.
Cited by
-
Evaluation of Fundus Blood Flow Perfusion in Patients with Diabetic Retinopathy after PPV with Fundus Color Doppler Based on Big Data Mining.J Healthc Eng. 2022 Feb 16;2022:7414165. doi: 10.1155/2022/7414165. eCollection 2022. J Healthc Eng. 2022. Retraction in: J Healthc Eng. 2023 Jul 12;2023:9867807. doi: 10.1155/2023/9867807. PMID: 35222891 Free PMC article. Retracted.
MeSH terms
Substances
LinkOut - more resources
Medical